Detalhe da pesquisa
1.
Risk stratification in multiple myeloma: Are we there yet?
Br J Haematol
; 204(5): 1585-1587, 2024 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38616560
2.
Chimeric antigen receptor and bispecific T-cell engager therapies in multiple myeloma patients with prior allogeneic transplantation.
Br J Haematol
; 204(3): 887-891, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-38054558
3.
The changing spectrum of infection with BCMA and GPRC5D targeting bispecific antibody (bsAb) therapy in patients with relapsed refractory multiple myeloma.
Haematologica
; 109(3): 906-914, 2024 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37646658
4.
Concomitant deletion of the short arm (del(1p13.3)) and amplification or gain (1q21) of chromosome 1 by fluorescence in situ hybridization are associated with a poor clinical outcome in multiple myeloma.
Cancer
; 129(16): 2491-2498, 2023 08 15.
Artigo
Inglês
| MEDLINE | ID: mdl-37282609
5.
Recommendations on prevention of infections during chimeric antigen receptor T-cell and bispecific antibody therapy in multiple myeloma.
Br J Haematol
; 203(5): 736-746, 2023 12.
Artigo
Inglês
| MEDLINE | ID: mdl-37287117
6.
Clinical efficacy of retreatment of daratumumab-based therapy (D2) in daratumumab-refractory multiple myeloma.
Eur J Haematol
; 110(6): 626-632, 2023 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-36752328
7.
Neutralizing antibody responses against SARS-CoV-2 in patients with plasma cell disorders who are on active treatment after two doses of mRNA vaccination.
Eur J Haematol
; 109(5): 458-464, 2022 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-35810359
8.
Interactions between cardiology and oncology drugs in precision cardio-oncology.
Clin Sci (Lond)
; 135(11): 1333-1351, 2021 06 11.
Artigo
Inglês
| MEDLINE | ID: mdl-34076246
9.
Combinatorial treatment for unresectable unicentric Castleman disease.
Eur J Haematol
; 107(4): 484-488, 2021 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-34242421
10.
Carfilzomib, cyclophosphamide, and dexamethasone (KCd) for the treatment of triple-class relapsed/refractory multiple myeloma (RRMM).
Eur J Haematol
; 107(6): 602-608, 2021 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-34378251
11.
Daratumumab in high-risk relapsed/refractory multiple myeloma patients: adverse effect of chromosome 1q21 gain/amplification and GEP70 status on outcome.
Br J Haematol
; 189(1): 67-71, 2020 04.
Artigo
Inglês
| MEDLINE | ID: mdl-31820442
12.
Intractable hypercalcemia in a patient with multiple myeloma: An infectious etiology.
Transpl Infect Dis
; 22(5): e13354, 2020 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-32500970
13.
Bacteremias following autologous stem cell transplantation for multiple myeloma: Risk factors and outcomes.
Transpl Infect Dis
; 21(2): e13052, 2019 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-30689291
14.
Clinical characteristics and prognostic factors in multiple myeloma patients with light chain deposition disease.
Am J Hematol
; 92(8): 739-745, 2017 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-28383130
15.
Tandem autologous stem cell transplantation in patients with persistent bone marrow minimal residual disease after first transplantation in multiple myeloma.
Am J Hematol
; 97(6): E195-E198, 2022 06 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35285981
16.
Corneal toxicity with belantamab mafodotin: Multi-institutional real-life experience.
Am J Hematol
; 97(12): E451-E453, 2022 12.
Artigo
Inglês
| MEDLINE | ID: mdl-36097868
17.
Clinical efficacy of sequencing CD38 targeting monoclonal antibodies in relapsed refractory multiple myeloma: A multi-institutional experience.
Am J Hematol
; 97(7): E276-E280, 2022 07.
Artigo
Inglês
| MEDLINE | ID: mdl-35472167
18.
Clinical characteristics of testicular extramedullary involvement in multiple myeloma.
Am J Hematol
; 96(3): E77-E81, 2021 03 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33338289
19.
Persistent bone marrow minimal residual disease as a "high-risk" disease feature in multiple myeloma.
Am J Hematol
; 96(9): E341-E344, 2021 09 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34050985
20.
Gastrointestinal histoplasmosis in a patient after autologous stem cell transplant for multiple myeloma.
Transpl Infect Dis
; 18(6): 939-941, 2016 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-27696648